Health Economics & Outcomes Research (HEOR) Services Market Growth, Overview with Detailed Analysis 2021-2027| IQVIA, Pharmaceutical Product Development (PPD), Rti Health Solutions, UnitedHealth Group, and more
Health Economics & Outcomes Research (HEOR) Services Market Growth, Overview with Detailed Analysis 2021-2027| IQVIA, Pharmaceutical Product Development (PPD), RTI [...]
BridgeHead and Eclipse Advance Healthcare Integration with Clinical Trials
BridgeHead’s global partnership with Eclipse Clinical Technology brings together complementary solutions and services for the integration of healthcare data with [...]
Democrats say they are a party of science, but their drug pricing plans tell another story
New arrivalYou can now listen to Fox News articles. Democrats prefer to present themselves as a party of science, but [...]
The Best Opportunities for Marketers Within Telehealth
In April 2020, at the beginning of the pandemic, the use of telehealth surged with 32% of office and outpatient [...]
Cancer Patients May Get Faster and More Personalized Treatment as Result of Collaboration Between GE Healthcare, University of Cambridge and Addenbrooke’s Hospital – WorldNews
Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by [...]
Global Orphan Designated Drug Rare Disease Market Clinical Trials Development Report
NEW DELHI Global Orphan Drugs Clinical Trials Insight Report Highlights: Clinical Insight On More Than 400 Marketed Orphan Drugs Read [...]
Investing in Pharmaceutical Companies
In the life sciences sector, pharmaceutical companies work towards bringing new cures to the market and improving treatments available for [...]
Navigating the CURES Act and Patient Access Final Rules: 7 Key Insights for Payers
ZeOmega now provides a guide listing seven things payers need to understand to comply with the CURES Act Final Rule [...]
Will Rob Califf’s industry ties sink his FDA commissioner nomination?
Dr. Rob Califf’s extensive industry ties cast uncertainty on his nomination for FDA commissioner. The nominee’s financial disclosures, released this [...]
Deadline for ASHEcon 2022 extended to December 10th
The American Society of Health Economists (ASHEcon) has extended the deadline for abstracts at their 2022 meeting to December 10th, [...]
Call for Abstracts: ISPOR 2022
Session and abstract submissions are now open for ISPOR 2022, the preeminent health economics and outcomes research conference. ISPOR 2022 [...]
New Technology Adoption by Care Teams is Built on Trust
Providers' reticence to use new EHR technology is built on poor training and lack of trust, according to a new [...]
Navigating the FDA Real-Time Oncology Review Process for Sponsors
Started in 2018, the FDA’s “Real-Time Oncology Review (ROTR)” project gives sponsors a head start on the application review [...]
“Specialty Pharmacy’s Post-Pandemic Outlook” Asembia 2021 Keynote Recap
The future of specialty pharmacy in the post-pandemic world was the topic of the October 27th keynote sessions at Asembia [...]
Now Available: Economic & Related Consulting Service Revenues WORLD REPORT + DATABASE
Research and Markets has released their Economic & Related Consulting Service Revenues World Report + Database, which covers products and [...]
“The Power of Patient Advocacy” – Value & Outcomes Spotlight Seeks Submissions
ISPOR’s journal Value & Outcomes Spotlight welcomes submissions for its January/February 2022 issue, which is themed, “The Power of Patient [...]
ISPOR Signal Series: The New Science of Cause and Effect
The next ISPOR Signal series event will feature Judea Pearl, professor of computer science and director of the Cognitive Systems [...]
Role of Pharmacy Benefit Managers Under Congressional Scrutiny
The role of pharmacy benefit managers (PBM) on patient out of pocket prices was examined by a US congressional hearing [...]
Gene Therapy for Beta Thalassemia Gene Under ICER Assessment
A gene therapy for beta thalassemia will undergo ICER assessment for comparative clinical effectiveness and value. Betibeglogene autotemcel (Zynteglo/LentiGlobin) from [...]
Insurers Refuse to Pay for New Alzheimer’s Drug Without Evidence of Efficacy
Twenty-five major insurers will not pay for Biogen’s Alzheimer’s drug Aduhelm without further proof of efficacy, according to results from [...]
ISPOR Calls for Nominations for President-Elect of their 2022-2023 Board of Directors
ISPOR is seeking nominations for president-elect on the 2022-2023 ISPOR Board of Directors. In addition, there will be three vacancies [...]
EMA Issues Guideline on RWE in Registry-Based Studies
The European Medicines Agency (EMA) has released new guidelines for using and generating RWE in registry-based studies. The guideline highlighted [...]
xCures Releases xDECIDE Platform to Personalize Cancer Care Using RWD
Released earlier this month, the xDECIDE platform helps doctors choose the optimal treatment strategy for cancer patients, according to a [...]
Changing Dynamics Between NICE and Pharmaceutical Industry
Recent shifts in the UK’s National Institute for Health and Care Excellence’s (NICE) approach to health technology assessment (HTA) are [...]
Impacts of the Build Back Better Act on the Healthcare Industry
With the Build Back Better Act inching through the legislature, uncertainty is building regarding its effects on the healthcare industry. [...]